Ikena Oncology, Inc. (IKNA) Social Stream

Ikena Oncology, Inc. (IKNA): $4.20

-0.23 (-5.19%)

POWR Rating

Component Grades













Add IKNA to Watchlist
Sign Up

Industry: Biotech


of 399

in industry

Ikena Oncology Inc (IKNA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering IKNA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-18 3 $27 $27 $27 $6.05 346.28%
2021-12-27 4 $27 $25 $26 $6.05 329.75%

The Trend in the Analyst Price Target

Over the past 100 days, IKNA's average price target has gone down $1.

Over the past 35 weeks, IKNA's average upside potential has been 99.35%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-26 NA 30 27 28.5 14.37 98.33%
2021-07-24 NA 30 27 28.5 10.90 161.47%
2021-08-04 NA 30 27 28.5 10.00 185%
2021-08-12 3 27 27 27.0 11.03 144.79%
2021-08-28 3 27 27 27.0 13.29 103.16%

IKNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Ikena Oncology Inc's variance in analysts' estimates is lower than 90.86% of them.
  • IKNA has a higher upside potential (average analyst target price relative to current price) than 280.52% of all US stocks.
  • In the context of Pharmaceutical Products stocks, Ikena Oncology Inc's number of analysts covering the stock is greater than 58.56% of them.
  • Ikena Oncology Inc's average analyst price target is higher than 183.02% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Ikena Oncology Inc are IDRA, ICVX, and HUMA.

What is the outlook for IKNA? Use POWR Ratings for clearer insight into price direction.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4013 seconds.